Hansen, B. Et Al. 2023. Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database. EASL Congress 2023 , (Vienna, Austria), 969-970.

Hansen, B., Valcheva, V., Yu, Q., Wessel, D. V., Thompson, R., Gonzalès, E., ... Jankowska, I.(2023). Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database . EASL Congress 2023 (pp.969-970). Vienna, Austria

Hansen, Betina Et Al. "Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database," EASL Congress 2023, Vienna, Austria, 2023

Hansen, Betina Et Al. "Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database." EASL Congress 2023 , Vienna, Austria, pp.969-970, 2023

Hansen, B. Et Al. (2023) . "Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database." EASL Congress 2023 , Vienna, Austria, pp.969-970.

@conferencepaper{conferencepaper, author={Betina Hansen Et Al. }, title={Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database}, congress name={EASL Congress 2023}, city={Vienna}, country={Austria}, year={2023}, pages={969-970} }